Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.391 USD | -4.40% | +11.08% | -45.85% |
Apr. 01 | Trevena, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 01 | Trevena, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Medicines for Central Nervous System Disorders
100.0
%
| 0 | 100.0 % | 3 | 100.0 % | -847.61% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 3 | 100.0 % | -847.61% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Carrie Bourdow
CEO | Chief Executive Officer | 61 | 15-05-03 |
Barry Shin
DFI | Director of Finance/CFO | 52 | 19-06-24 |
Angela Bagley
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Chief Tech/Sci/R&D Officer | - | 21-03-31 | |
Joel S. Solomon
CMP | Compliance Officer | - | 15-01-31 |
Mark Demitrack
CTO | Chief Tech/Sci/R&D Officer | 66 | 18-05-20 |
Patricia Drake
PRN | Corporate Officer/Principal | - | 21-11-10 |
Robert Yoder
PRN | Corporate Officer/Principal | 59 | 18-06-10 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jake Nunn
BRD | Director/Board Member | 54 | 13-06-30 |
Scott Braunstein
BRD | Director/Board Member | 60 | 18-08-31 |
Mark Corrigan
BRD | Director/Board Member | 66 | 23-07-17 |
Anne Phillips
BRD | Director/Board Member | 70 | 14-12-15 |
Barbara Yanni
BRD | Director/Board Member | 69 | 14-06-30 |
Carrie Bourdow
CEO | Chief Executive Officer | 61 | 15-05-03 |
Marvin Johnson
BRD | Director/Board Member | 61 | 21-03-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,321,010 | 18,152,018 ( 99.08 %) | 0 | 99.08 % |
Company contact information
Trevena, Inc.
955 Chesterbrook Boulevard Suite 110
19087, Chesterbrook
+610 354 8840
http://www.trevena.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.85% | 7.49M | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- TRVN Stock
- Company Trevena, Inc.